换一批Confirmatory versus explorative endpoint analysis: Decision-making on the basis of evidence available from market authorization and early benefit assessment for oncology drugs.
第一作者：
Ines,Niehaus
第一单位：
Cologne Institute for Health Economics and Clinical Epidemiology, University of Cologne, Cologne, Germany. Electronic address: i.niehaus@gmx.net.
作者：
主题词
抗肿瘤药(Antineoplastic Agents);决策(Decision Making);药物批准(Drug Approval);德国(Germany);人类(Humans);生活质量(Quality of Life);危险性评估(Risk Assessment);技术评估, 生物医学(Technology Assessment, Biomedical)
DOI
10.1016/j.healthpol.2018.03.017
PMID
29605527
发布时间
2018-11-26
- 浏览15
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
